Primary angioplasty: the past, the present and the future

Related Experiment Video

Updated: Oct 2, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

A Oomman1, P Ramachandran

  • 1Apollo Hospitals, Chennai, India.

The Journal of the Association of Physicians of India
|February 12, 2002
PubMed

Insights

Primary angioplasty (PTCA) offers benefits for acute myocardial infarction but requires skilled performance in suitable labs. It is a viable alternative to thrombolysis, especially for specific patient groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Primary percutaneous coronary intervention (PTCA) for acute myocardial infarction (AMI) has theoretical advantages.
  • These benefits, including improved antegrade flow and reduced intracranial hemorrhage, have not consistently translated from trials to community practice.

Purpose of the Study:

  • To evaluate the effectiveness and applicability of primary PTCA in the management of acute myocardial infarction.
  • To identify patient subgroups and settings where primary PTCA is most beneficial.

Main Methods:

  • Review of randomized trials and clinical data on primary angioplasty in acute myocardial infarction.
  • Analysis of outcomes in sophisticated centers versus community settings.
  • Assessment of PTCA in specific patient populations, including those with cardiogenic shock or contraindications to thrombolysis.

Main Results:

  • Primary PTCA shows promise but its success in community settings is variable.
  • Timely and skilled performance in appropriate laboratory settings is crucial for successful outcomes.
  • PTCA is recommended for patients with cardiogenic shock and those unable to receive thrombolytic therapy.

Conclusions:

  • Primary PTCA is a suitable alternative to thrombolytic therapy for acute myocardial infarction when performed correctly and timely.
  • Future reperfusion strategies may involve a combination of thrombolytics, glycoprotein IIb/IIIa inhibitors, and primary angioplasty.

More Related Videos

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...